211 related articles for article (PubMed ID: 15528294)
1. Response of homocysteine, cystathionine, and methylmalonic acid to vitamin treatment in dialysis patients.
Obeid R; Kuhlmann MK; Köhler H; Herrmann W
Clin Chem; 2005 Jan; 51(1):196-201. PubMed ID: 15528294
[TBL] [Abstract][Full Text] [Related]
2. Effect of multivitamin supplementation on the homocysteine and methylmalonic acid blood concentrations in women over the age of 60 years.
Wolters M; Hermann S; Hahn A
Eur J Nutr; 2005 Mar; 44(3):183-92. PubMed ID: 15309436
[TBL] [Abstract][Full Text] [Related]
3. Hydroxocobalamin reduces hyperhomocysteinemia in end-stage renal disease.
Elian KM; Hoffer LJ
Metabolism; 2002 Jul; 51(7):881-6. PubMed ID: 12077735
[TBL] [Abstract][Full Text] [Related]
4. Supplementation with vitamin B12 decreases homocysteine and methylmalonic acid but also serum folate in patients with end-stage renal disease.
Dierkes J; Domröse U; Ambrosch A; Schneede J; Guttormsen AB; Neumann KH; Luley C
Metabolism; 1999 May; 48(5):631-5. PubMed ID: 10337865
[TBL] [Abstract][Full Text] [Related]
5. Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention.
Bleie Ø; Refsum H; Ueland PM; Vollset SE; Guttormsen AB; Nexo E; Schneede J; Nordrehaug JE; Nygård O
Am J Clin Nutr; 2004 Sep; 80(3):641-8. PubMed ID: 15321804
[TBL] [Abstract][Full Text] [Related]
6. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
[TBL] [Abstract][Full Text] [Related]
7. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
8. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
Hyndman ME; Manns BJ; Snyder FF; Bridge PJ; Scott-Douglas NW; Fung E; Parsons HG
Metabolism; 2003 Feb; 52(2):168-72. PubMed ID: 12601627
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum levels of methylmalonic acid and homocysteine in elderly people. A population-based intervention study.
Björkegren K; Svärdsudd K
J Intern Med; 1999 Dec; 246(6):603-11. PubMed ID: 10620093
[TBL] [Abstract][Full Text] [Related]
10. Glomerular filtration rate as measured by serum cystatin C is an important determinant of plasma homocysteine and serum methylmalonic acid in the elderly.
Lewerin C; Ljungman S; Nilsson-Ehle H
J Intern Med; 2007 Jan; 261(1):65-73. PubMed ID: 17222169
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia and endothelial function in young subjects: effects of vitamin supplementation.
Hirsch S; Pia De la Maza M; Yañez P; Glasinovic A; Petermann M; Barrera G; Gattas V; Escobar E; Bunout D
Clin Cardiol; 2002 Nov; 25(11):495-501. PubMed ID: 12430779
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].
Sánchez Alvarez JE; Pérez Tamajón L; Hernández D; Alvarez González A; Delgado P; Lorenzo V
Nefrologia; 2005; 25(3):288-96. PubMed ID: 16053010
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine, cystathionine, methylmalonic acid and B-vitamins in patients with renal disease.
Herrmann W; Schorr H; Geisel J; Riegel W
Clin Chem Lab Med; 2001 Aug; 39(8):739-46. PubMed ID: 11592444
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum levels of methylmalonic acid and homocysteine in elderly people. A population-based intervention study.
Björkegren K; Svärdsudd K
J Intern Med; 1999 Sep; 246(3):317-24. PubMed ID: 10476000
[TBL] [Abstract][Full Text] [Related]
15. Role of homocysteine, cystathionine and methylmalonic acid measurement for diagnosis of vitamin deficiency in high-aged subjects.
Herrmann W; Schorr H; Bodis M; Knapp JP; Müller A; Stein G; Geisel J
Eur J Clin Invest; 2000 Dec; 30(12):1083-9. PubMed ID: 11122323
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine levels in patients treated with lipid apheresis: effect of a vitamin therapy.
Julius U; Pietzsch J; Gromeier S; Schorr H; Herrmann W
Eur J Clin Invest; 2001 Aug; 31(8):667-71. PubMed ID: 11473567
[TBL] [Abstract][Full Text] [Related]
17. Parenteral vitamin B12 reduces hyperhomocysteinemia in end-stage renal disease.
Kaplan LN; Mamer OA; Hoffer LJ
Clin Invest Med; 2001 Feb; 24(1):5-11. PubMed ID: 11266032
[TBL] [Abstract][Full Text] [Related]
18. Creatine supplementation does not decrease total plasma homocysteine in chronic hemodialysis patients.
Taes YE; Delanghe JR; De Bacquer D; Langlois M; Stevens L; Geerolf I; Lameire NH; De Vriese AS
Kidney Int; 2004 Dec; 66(6):2422-8. PubMed ID: 15569335
[TBL] [Abstract][Full Text] [Related]
19. Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: a placebo-controlled randomized study.
Lewerin C; Matousek M; Steen G; Johansson B; Steen B; Nilsson-Ehle H
Am J Clin Nutr; 2005 May; 81(5):1155-62. PubMed ID: 15883442
[TBL] [Abstract][Full Text] [Related]
20. Disturbed homocysteine and methionine cycle intermediates S-adenosylhomocysteine and S-adenosylmethionine are related to degree of renal insufficiency in type 2 diabetes.
Herrmann W; Schorr H; Obeid R; Makowski J; Fowler B; Kuhlmann MK
Clin Chem; 2005 May; 51(5):891-7. PubMed ID: 15774574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
